These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Quantitative and Correlational Analysis of Brain and Spleen Immune Cellular Responses Following Cerebral Ischemia. Liu Q; Sorooshyari SK Front Immunol; 2021; 12():617032. PubMed ID: 34194419 [TBL] [Abstract][Full Text] [Related]
24. Regulatory CD8(+)CD122 (+) T-cells predominate in CNS after treatment of experimental stroke in male mice with IL-10-secreting B-cells. Bodhankar S; Chen Y; Lapato A; Vandenbark AA; Murphy SJ; Saugstad JA; Offner H Metab Brain Dis; 2015 Aug; 30(4):911-924. PubMed ID: 25537181 [TBL] [Abstract][Full Text] [Related]
25. The role of Interleukin-33 in the modulation of splenic T-cell immune responses after experimental ischemic stroke. Xiao W; Guo S; Chen L; Luo Y J Neuroimmunol; 2019 Aug; 333():576970. PubMed ID: 31146104 [TBL] [Abstract][Full Text] [Related]
26. Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke. Zhang B; Subramanian S; Dziennis S; Jia J; Uchida M; Akiyoshi K; Migliati E; Lewis AD; Vandenbark AA; Offner H; Hurn PD J Immunol; 2010 Apr; 184(8):4087-94. PubMed ID: 20304826 [TBL] [Abstract][Full Text] [Related]
28. Platelets and lymphocytes drive progressive penumbral tissue loss during middle cerebral artery occlusion in mice. Schuhmann MK; Bieber M; Franke M; Kollikowski AM; Stegner D; Heinze KG; Nieswandt B; Pham M; Stoll G J Neuroinflammation; 2021 Feb; 18(1):46. PubMed ID: 33602266 [TBL] [Abstract][Full Text] [Related]
29. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. Offner H; Subramanian S; Parker SM; Wang C; Afentoulis ME; Lewis A; Vandenbark AA; Hurn PD J Immunol; 2006 Jun; 176(11):6523-31. PubMed ID: 16709809 [TBL] [Abstract][Full Text] [Related]
30. Bim Deletion Reduces Functional Deficits Following Ischemic Stroke in Association with Modulation of Apoptosis and Inflammation. Glab JA; Puthalakath H; Zhang SR; Vinh A; Drummond GR; Sobey CG; De Silva TM; Kim HA Neuromolecular Med; 2022 Dec; 24(4):405-414. PubMed ID: 35149957 [TBL] [Abstract][Full Text] [Related]
31. Infiltration and persistence of lymphocytes during late-stage cerebral ischemia in middle cerebral artery occlusion and photothrombotic stroke models. Feng Y; Liao S; Wei C; Jia D; Wood K; Liu Q; Wang X; Shi FD; Jin WN J Neuroinflammation; 2017 Dec; 14(1):248. PubMed ID: 29246244 [TBL] [Abstract][Full Text] [Related]
32. Role of dihydrotestosterone in post-stroke peripheral immunosuppression after cerebral ischemia. Dziennis S; Akiyoshi K; Subramanian S; Offner H; Hurn PD Brain Behav Immun; 2011 May; 25(4):685-95. PubMed ID: 21262338 [TBL] [Abstract][Full Text] [Related]
33. Lipopolysaccharide preconditioning increased the level of regulatory B cells in the spleen after acute ischaemia/reperfusion in mice. Wang Z; Zhou Y; Yu Y; He K; Cheng LM Brain Res; 2018 Dec; 1701():46-57. PubMed ID: 29803621 [TBL] [Abstract][Full Text] [Related]
34. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720 [TBL] [Abstract][Full Text] [Related]
37. Early retinal inflammatory biomarkers in the middle cerebral artery occlusion model of ischemic stroke. Ritzel RM; Pan SJ; Verma R; Wizeman J; Crapser J; Patel AR; Lieberman R; Mohan R; McCullough LD Mol Vis; 2016; 22():575-88. PubMed ID: 27293375 [TBL] [Abstract][Full Text] [Related]
38. Albumin induces neuroprotection against ischemic stroke by altering Toll-like receptor 4 and regulatory T cells in mice. Wang M; Wang Y; He J; Wei S; Zhang N; Liu F; Liu X; Kang Y; Yao X CNS Neurol Disord Drug Targets; 2013 Mar; 12(2):220-7. PubMed ID: 23394540 [TBL] [Abstract][Full Text] [Related]